Economics of screening for carcinoma of the prostate

S. A. Optenberg, I. M. Thompson

Research output: Contribution to journalArticle

114 Citations (Scopus)

Abstract

The proposition of whether to adopt a system of mass screening for carcinoma of the prostate in the U.S. is well suited to the clinical decision analysis approach. The authors demonstrate this by using available data, which suggest that offering a screening program to all men ages 50 to 70 would be prohibitively expensive. The method also permits calculation of the eventual morbidity of screening and its costs. This analysis demonstrates the importance of attempting to predict ultimate patient outcomes before implementing any health care strategy as standard.

Original languageEnglish (US)
Pages (from-to)719-737
Number of pages19
JournalUrologic Clinics of North America
Volume17
Issue number4
StatePublished - 1990

Fingerprint

Mass Screening
Decision Support Techniques
Prostate
Economics
Morbidity
Carcinoma
Delivery of Health Care
Costs and Cost Analysis

ASJC Scopus subject areas

  • Urology

Cite this

Optenberg, S. A., & Thompson, I. M. (1990). Economics of screening for carcinoma of the prostate. Urologic Clinics of North America, 17(4), 719-737.

Economics of screening for carcinoma of the prostate. / Optenberg, S. A.; Thompson, I. M.

In: Urologic Clinics of North America, Vol. 17, No. 4, 1990, p. 719-737.

Research output: Contribution to journalArticle

Optenberg, SA & Thompson, IM 1990, 'Economics of screening for carcinoma of the prostate', Urologic Clinics of North America, vol. 17, no. 4, pp. 719-737.
Optenberg, S. A. ; Thompson, I. M. / Economics of screening for carcinoma of the prostate. In: Urologic Clinics of North America. 1990 ; Vol. 17, No. 4. pp. 719-737.
@article{b4ca63c6c2064915bd82c55f71920529,
title = "Economics of screening for carcinoma of the prostate",
abstract = "The proposition of whether to adopt a system of mass screening for carcinoma of the prostate in the U.S. is well suited to the clinical decision analysis approach. The authors demonstrate this by using available data, which suggest that offering a screening program to all men ages 50 to 70 would be prohibitively expensive. The method also permits calculation of the eventual morbidity of screening and its costs. This analysis demonstrates the importance of attempting to predict ultimate patient outcomes before implementing any health care strategy as standard.",
author = "Optenberg, {S. A.} and Thompson, {I. M.}",
year = "1990",
language = "English (US)",
volume = "17",
pages = "719--737",
journal = "Urologic Clinics of North America",
issn = "0094-0143",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Economics of screening for carcinoma of the prostate

AU - Optenberg, S. A.

AU - Thompson, I. M.

PY - 1990

Y1 - 1990

N2 - The proposition of whether to adopt a system of mass screening for carcinoma of the prostate in the U.S. is well suited to the clinical decision analysis approach. The authors demonstrate this by using available data, which suggest that offering a screening program to all men ages 50 to 70 would be prohibitively expensive. The method also permits calculation of the eventual morbidity of screening and its costs. This analysis demonstrates the importance of attempting to predict ultimate patient outcomes before implementing any health care strategy as standard.

AB - The proposition of whether to adopt a system of mass screening for carcinoma of the prostate in the U.S. is well suited to the clinical decision analysis approach. The authors demonstrate this by using available data, which suggest that offering a screening program to all men ages 50 to 70 would be prohibitively expensive. The method also permits calculation of the eventual morbidity of screening and its costs. This analysis demonstrates the importance of attempting to predict ultimate patient outcomes before implementing any health care strategy as standard.

UR - http://www.scopus.com/inward/record.url?scp=0025011413&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025011413&partnerID=8YFLogxK

M3 - Article

C2 - 1699340

AN - SCOPUS:0025011413

VL - 17

SP - 719

EP - 737

JO - Urologic Clinics of North America

JF - Urologic Clinics of North America

SN - 0094-0143

IS - 4

ER -